Aixtron’s Order Book Swells But Profits Lag – All Eyes on July 30 Results
29.06.2026 - 15:53:07 | boerse-global.de
The disconnect at Aixtron is widening with every customer announcement: a flood of new orders for optoelectronics systems, yet operating earnings that remain mired in the red. Investors have taken notice, sending the stock into a double-digit retreat even as the company reaffirms its upgraded outlook. The market is no longer questioning demand – it is demanding proof that orders will translate into visible revenue.
Shares traded near €52.46 on Friday, just below their 50-day moving average of €52.60. That level has become a critical technical pivot after the stock shed roughly 13% in a single week. Despite the pullback, Aixtron still trades 168% higher year to date, a gain that leaves little room for execution missteps.
The recent order flow is undeniably robust. Lumentum placed orders for G10-AsP systems to support high-speed optical links for AI data centres, while ROHM is ramping up production of gallium nitride (GaN) epitaxial wafers at its Hamamatsu facility. The Massachusetts Institute of Technology’s Lincoln Laboratory also acquired two Hyperion systems – though these are for research purposes and do not yet represent a near-term series-production driver.
Aixtron itself has described the operational environment as improved, and the company raised its full-year guidance on the back of stronger optoelectronics demand. The Q1 order intake came in at €171 million, a 30% jump year-on-year, pushing the order backlog to nearly €360 million. Yet the same quarter delivered a hefty operating loss, weighed down by lower delivery volumes and one-time effects from headcount reductions.
Should investors sell immediately? Or is it worth buying Aixtron?
Management has signalled that larger system deliveries will begin in Q2, targeting revenue of around €110 million for the quarter. The full-year revenue forecast stands at €560 million. All eyes are now on the half-year report due 30 July, when the market will get its first concrete look at whether those deliveries are materialising.
Until then, the stock is caught between two competing narratives. On the bullish side, Aixtron has named real customers, not just generic end markets. Lumentum and ROHM offer genuine commercial traction in both optoelectronics and GaN power electronics, potentially reducing reliance on any single demand segment. The stock’s ability to hold its 50-day moving average could be read as a healthy consolidation within an intact uptrend.
The bearish case starts with valuation. Even after the sell-off, the stock sits 337% above its 52-week low, leaving scant buffer for disappointment. The RSI has cooled to 45, but an annualised volatility of 67% means small shocks can trigger outsized moves. Operationally, the weakness in silicon carbide (SiC) equipment persists, GaN orders remain modest, and Aixtron’s own risk factors – cancellations, delays, extended qualification cycles – are extensive. The MIT purchase, while flattering for the technology, should not be mistaken for a series revenue catalyst.
Aixtron at a turning point? This analysis reveals what investors need to know now.
The 30 July report will either validate the bull case by showing a clear transition from orders to shipments, or it will expose the gap between backlog and profitability. If Aixtron can demonstrate that its optoelectronics orders are generating real turnover, the recent pullback may prove to be a buying opportunity. If not, the stock’s wide distance from its 200-day moving average leaves ample room for a deeper re-rating.
Ad
Aixtron Stock: New Analysis - 29 June
Fresh Aixtron information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
